Literature DB >> 9409353

Multiple-system atrophy is genetically distinct from identified inherited causes of spinocerebellar degeneration.

O Bandmann1, M G Sweeney, S E Daniel, G K Wenning, N Quinn, C D Marsden, N W Wood.   

Abstract

Multiple system atrophy (MSA) is a neurodegenerative disorder of unknown cause. The only case-control study conducted in MSA patients to date suggested a possible contributory genetic component in the pathogenesis of this disorder. The aim of this study was to evaluate a possible overlap between clinically or pathologically well-defined MSA and other conditions with an identified genetic defect causing spinocerebellar degeneration in humans or mutant mice strains. The spinocerebellar ataxia type 1 and 3 genes (SCA1 and SCA3) were analyzed for a pathologic expansion in 80 patients with MSA to evaluate a possible overlap between MSA and SCA1 or SCA3. Weaver mice and lurcher mice are animal models for spinocerebellar degeneration; both share pathologic features with MSA. We sequenced the H5 pore region of the human homologue of the weaver mouse gene, hiGIRK2, in all our patients. In lurcher mice, previous biochemical studies have shown a decreased intracellular response to insulin-like growth factor 1 (IGF-1) in the cerebellar cortex, and we thus investigated the possibility of an allelic association between MSA and the receptor for IGF-1. In addition, we evaluated a possible involvement of the ciliary neurotrophic factor gene (CNTF) and examined the role of HLA-A32 to clarify the conflicting data from previous studies. No changes were detected in any of the analyzed genes. Our studies strongly suggest that MSA is an autonomous syndrome distinct from identified genetic causes for spinocerebellar degeneration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9409353     DOI: 10.1212/wnl.49.6.1598

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 2.  Multiple system atrophy: clues from inclusions.

Authors:  R Castellani
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 3.  Multiple system atrophy: cellular and molecular pathology.

Authors:  D J Burn; E Jaros
Journal:  Mol Pathol       Date:  2001-12

4.  Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy.

Authors:  Sarah J Lincoln; Owen A Ross; Nicole M Milkovic; Dennis W Dickson; Alex Rajput; Christopher A Robinson; Spiridon Papapetropoulos; Deborah C Mash; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-02-08       Impact factor: 4.891

5.  Widespread alterations of alpha-synuclein in multiple system atrophy.

Authors:  D W Dickson; W Liu; J Hardy; M Farrer; N Mehta; R Uitti; M Mark; T Zimmerman; L Golbe; J Sage; A Sima; C D'Amato; R Albin; S Gilman; S H Yen
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

6.  Genetic players in multiple system atrophy: unfolding the nature of the beast.

Authors:  Sylvia Stemberger; Sonja W Scholz; Andrew B Singleton; Gregor K Wenning
Journal:  Neurobiol Aging       Date:  2011-05-24       Impact factor: 4.673

Review 7.  Multiple system atrophy: genetic or epigenetic?

Authors:  Edith Sturm; Nadia Stefanova
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.